Sculptor Capital LP Abb Vie Inc. Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $54.1 Million - $68.7 Million	-392,858 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $15.2 Million - $18.9 Million	115,366 Added 41.57%	392,858 $63.7 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $29.8 Million - $37.7 Million	277,492 New	277,492 $37.6 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.